Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Expert Opinion on Investigational Drugs|April 24, 2012
Angiotensin II type 2 receptor agonists--where should they be applied?Ulrike Muscha Steckelings, Thomas UngerCell Metabolism|December 26, 2006
Angiotensin in the kidney: a key to understanding hypertension?Ulrike Muscha Steckelings, Rainer Rettig, Thomas UngerDrug News & Perspectives|April 7, 2010
The angiotensin AT2 receptor in inflammationFranziska Rompe, Thomas Unger, Ulrike Muscha SteckelingsFundamental & Clinical Pharmacology|October 13, 2009
The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targetsUlrike Muscha Steckelings, Franziska Rompe, Elena Kaschina, et al.Expert Opinion on Emerging Drugs|September 13, 2011
Emerging drugs which target the renin-angiotensin-aldosterone systemUlrike Muscha Steckelings, Ludovit Paulis, Thomas Unger, et al.Current Hypertension Reports|January 14, 2014
AT(2) receptor and tissue injury: therapeutic implicationsPawel Namsolleck, Chiara Recarti, Sébastien Foulquier, et al.Hypertension (Dallas, Tex. : 1979)|August 23, 2017
Angiotensin II Type 2 Receptor and Receptor Mas Are Colocalized and Functionally Interdependent in Obese Zucker Rat KidneySanket N Patel, Quaisar Ali, Preethi Samuel, et al.Drugs|December 4, 2015
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic DisordersLudovit Paulis, Sébastien Foulquier, Pawel Namsolleck, et al.Acta Physiologica (Oxford, England)|April 9, 2019
Anti-fibrotic mechanisms of angiotensin AT<sub>2</sub> -receptor stimulationColin Sumners, Antonio Augusto Peluso, Andreas Houe Haugaard, et al.Current Opinion in Pharmacology|February 14, 2015
Angiotensin type 2 receptors: blood pressure regulation and end organ damageColin Sumners, Annette D de Kloet, Eric G Krause, et al.Pageof 3